Results

Total Results: 61 records

Showing results for "crc intervention".

1. Final Research Plan: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
   May 14, 2020 - to In Progress page Expand All Analytic Framework Abbreviations: CRC … aspirin use in patients without known cardiovascular disease (CVD) reduce CVD and colorectal cancer (CRC … What is the effect of aspirin discontinuation on CVD, CRC, all-cause mortality, and bleeding outcomes … age ≥40 years without known CVD and at average risk for CRC or unselected for CRC risk * Other selected … medications (e.g., warfarin) Comparisons Placebo or no treatment Any active substance or intervention

2. Final Research Plan: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/aspirin-to-prevent-cardiovascular-disease-preventive-medication
   May 14, 2020 - Framework Abbreviations: CRC … aspirin use in patients without known cardiovascular disease (CVD) reduce CVD and colorectal cancer (CRC … What is the effect of aspirin discontinuation on CVD, CRC, all-cause mortality, and bleeding outcomes … age ≥40 years without known CVD and at average risk for CRC or unselected for CRC risk * Other selected … medications (e.g., warfarin) Comparisons Placebo or no treatment Any active substance or intervention

3. Draft Research Plan: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/aspirin-use-to-prevent-cardiovascular-disease-and-colorectal-cancer-preventive-medication
   January 30, 2020 - Expand All Proposed Analytic Framework Abbreviations: CRC … aspirin use in patients without known cardiovascular disease (CVD) reduce CVD and colorectal cancer (CRC … What is the effect of aspirin discontinuation on CVD, CRC, all-cause mortality, and bleeding outcomes … CVD and at average risk for CRC or unselected for CRC risk * Other selected nongeneralizable populations … medications (e.g., warfarin) Comparisons Placebo or no treatment Any active substance or intervention

4. Draft Research Plan: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
   January 30, 2020 - Expand All Proposed Analytic Framework Abbreviations: CRC … aspirin use in patients without known cardiovascular disease (CVD) reduce CVD and colorectal cancer (CRC … What is the effect of aspirin discontinuation on CVD, CRC, all-cause mortality, and bleeding outcomes … CVD and at average risk for CRC or unselected for CRC risk * Other selected nongeneralizable populations … medications (e.g., warfarin) Comparisons Placebo or no treatment Any active substance or intervention

5. Evidence Summary: Aspirin Use to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer
   April 11, 2016 - † Minimum intended intervention duration. … Figure 3 displays two forest plots of studies reporting the relative risk for the intervention group … Appendix Figure 2 displays a forest plot of studies reporting the relative risk for the intervention … Appendix Figure 3 displays a forest plot of studies reporting the relative risk for the intervention … Appendix Figure 4 displays a forest plot of studies reporting the relative risk for the intervention

6. Archived: Evidence Summary: Aspirin Use to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
   April 11, 2016 - † Minimum intended intervention duration. … Figure 3 displays two forest plots of studies reporting the relative risk for the intervention group … Appendix Figure 2 displays a forest plot of studies reporting the relative risk for the intervention … Appendix Figure 3 displays a forest plot of studies reporting the relative risk for the intervention … Appendix Figure 4 displays a forest plot of studies reporting the relative risk for the intervention

7. Screening for Colorectal Cancer: Consumer Guide (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/Yuj3Md9rNMCvcktoBsWjh3
   June 01, 2016 - The main benefit of CRC screening is that it can reduce the chance that a person will die from CRC. … CRC screening also has potential harms. … When the Task Force recommends an intervention (Grade A), it is because it has substantially more potential … Notes 1 screening Using a test to detect CRC or abnormalities that might lead to CRC. … Deciding Whether to Be Screened for CRC Evidence clearly shows that CRC screening can reduce the risk

8. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/Xbtq4oDQwVo7KgmSjnnDbz
   November 01, 2021 - Intervention: study used an excluded intervention or screening approach. … ,60 2014 Fair Norway 50-64 Intervention: 20 572 Control: 78 220 1 NA 11.0 20.4 1.4 Intervention: 31 … 55-64 Intervention: 17 136 Control: 17 136 1 NA 11.4 8.6 1.6 Intervention: 35 Control Group:44 0.78 … Intervention: 45 642 Control: 45 557 6 2 11 2.1 1.5 Intervention: 53 Control:64 0.84 (0.71-0.99) … Funen,33 2004 Good Denmark 45-75 Intervention: 30 967 Control: 30 966 9 2 17 1.0 2.8 Intervention:

9. Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/colorectal-cancer-screening
   June 15, 2016 - Summarized below are the results for CRC-specific mortality, as results for CRC incidence were consistent … with CRC mortality findings. … Intervention: study used an excluded intervention or screening approach. … , % e No. of CRC Deaths/ 100,000 Person-Years CRC Mortality, RR (95% CI … 60-64 Intervention: 34,144 Control: 34,164 2-3 1-9 19 3.8 i 2.2 Intervention: 53

10. Archived: Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/colorectal-cancer-screening-june-2016
    June 15, 2016 - Summarized below are the results for CRC-specific mortality, as results for CRC incidence were consistent … with CRC mortality findings. … Intervention: study used an excluded intervention or screening approach. … , % e No. of CRC Deaths/ 100,000 Person-Years CRC Mortality, RR (95% CI … 60-64 Intervention: 34,144 Control: 34,164 2-3 1-9 19 3.8 i 2.2 Intervention: 53

11. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/whbbEX529Ha4FyvsYv6uh6
    April 26, 2022 - Health outcomes 1 Harms of intervention 2 Aspirin Evidence reviews for the US Preventive Services … The primary outcomes for CRC benefits (KQ1) were CRC inci- dence and CRC mortality. … Intervention: Study did not use an included intervention. … Harms of Intervention Key Question 2. … /total (%) Intervention ControlOutcome Cardiovascular disease Peto OR (95% CI) 11 134 470 2511/67

12. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/2GDCmTe7akyrAHsTMbfz72
    May 06, 2022 - Health outcomes 1 Harms of intervention 2 Aspirin Evidence reviews for the US Preventive Services … The primary outcomes for CRC benefits (KQ1) were CRC inci- dence and CRC mortality. … Intervention: Study did not use an included intervention. … Harms of Intervention Key Question 2. … /total (%) Intervention ControlOutcome Cardiovascular disease Peto OR (95% CI) 11 134 470 2511/67

13. Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
    April 26, 2022 - English-language randomized clinical trials (RCTs) of low-dose aspirin (≤100mg/d) compared with placebo or no intervention … were eligible for inclusion if they were randomized clinical trials (RCTs), nonrandomized controlled intervention … Cancer of any type was a prespecified outcome in only 3 low-dose aspirin RCTs. 6 , 45 , 53 Benefits of Intervention … Harms of Intervention Key Question 2. … Intervention: Study did not use an included intervention.

14. Decision Analysis: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/decision-analysis-for-aspirin/aspirin-to-prevent-cardiovascular-disease-and-cancer
    April 11, 2016 - Intervention: Low-dose aspirin (≤100 mg/d). … , and CRC mortality. … Choice of Intervention Findings from the 3 coordinated, companion systematic evidence reviews were … Cardiology/American Heart Association risk calculator to specify baseline CVD risk in the model. 16 Intervention … Case 4 CRC benefit = none is equivalent to setting the CRC RR = 1.

15. Archived: Decision Analysis: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/decision-analysis-for-aspirin/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - Intervention: Low-dose aspirin (≤100 mg/d). … , and CRC mortality. … Choice of Intervention Findings from the 3 coordinated, companion systematic evidence reviews were … Cardiology/American Heart Association risk calculator to specify baseline CVD risk in the model. 16 Intervention … Case 4 CRC benefit = none is equivalent to setting the CRC RR = 1.

16. Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/_SfjkGNHBnLqn8ySe7kAdg
    April 01, 2016 - Intervention: Low-dose aspirin (≤100 mg/d). … , and CRC mortality. … Choice of Intervention Findings from the 3 coordinated, companion sys- tematic evidence reviews were … Intervention Effects Effects from using aspirin for primary prevention were modeled as RR modifications … Case 4 CRC benefit = none is equivalent to setting the CRC RR = 1.

17. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Njxn2r3qtWKdBf2_VhS2Aw
    April 01, 2016 - Does the effect of aspirin vary by delivery of intervention (e.g., dose, frequency, duration, formulation … Does the effect of aspirin vary by delivery of intervention (e.g., dose, frequency, duration, formulation … Does the effect of aspirin vary by delivery of intervention (e.g., dose, frequency, duration, formulation … Does the effect of aspirin vary by delivery of intervention (e.g., dose, frequency, duration, formulation … Does the effect of aspirin vary by delivery of intervention (e.g., dose, frequency, duration, formulation

18. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication
    March 15, 2007 - We extracted data by using the PICOS (participant, intervention and exposure, comparator, outcome, and … Measuring the dose effect depended on the intervention dose, the frequency and duration of use, and whether … , and CRC-related death. … not shown but included were acetylsalicylic acid (ASA) studies or studies that considered more than 1 intervention … No relevant intervention = 31. No relevant outcome = 17.

19. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
    March 15, 2007 - We extracted data by using the PICOS (participant, intervention and exposure, comparator, outcome, and … Measuring the dose effect depended on the intervention dose, the frequency and duration of use, and whether … , and CRC-related death. … not shown but included were acetylsalicylic acid (ASA) studies or studies that considered more than 1 intervention … No relevant intervention = 31. No relevant outcome = 17.

20. Modeling Study: Colorectal Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/modeling-study/colorectal-cancer-screening
    June 15, 2016 - developed within the National Cancer Institute–funded Cancer Intervention and Surveillance Modeling … (CRC-SPIN). … Cancer Intervention and Surveillance Modeling Network (CISNET) Model Registry. … Mandelblatt JS, Cronin KA, Bailey S, et al; Breast Cancer Working Group of the Cancer Intervention and … 28 28 27   Abbreviations: CRC, colorectal cancer; CRC-SPIN, CRC Simulated Population